Clinical trial
The Effect of Donepezil on Sedation and Other Symptoms
NCT00352664 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00352664 |
|---|---|
| Title | The Effect of Donepezil on Sedation and Other Symptoms |
| Official title | Donepezil for Cancer Patients With Sedation Related to Opioid Treatment: A Double-blind Placebo Controlled Randomized Study |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Pfizer Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Advanced Cancer |
| Intervention type | Drug |
| Interventions | Donepezil, Placebo |
| Enrollment | 27 |
| Start date | Nov 1, 2003 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jul 14, 2006 |
| Last update posted | May 9, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: